Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -65.53x is 96% above its 5-year average of -1763.13x, near the high end of its 5-year range (-18767.67x–479.50x).
As of the fiscal period ended Friday, March 31, 2023. 98.19% above its 12-month average of -3616.63x.
Reported quarterly interest coverage; no daily interpolation. Q1 FY2023 (2023-03-31): -65.53x.
INTEREST COVERAGE RATIO
-65.53x
INTEREST COVERAGE RATIO AVG TTM
-3616.63x
INTEREST COVERAGE RATIO AVG 3Y
-2533.14x
INTEREST COVERAGE RATIO AVG 5Y
-1763.13x
INTEREST COVERAGE RATIO AVG 10Y
-1630.27x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+98.19%
CURRENT VS 3Y AVG
+97.41%
CURRENT VS 5Y AVG
+96.28%
CURRENT VS 10Y AVG
+95.98%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.63x
median of 452 covered companies
CURRENT VS SECTOR MEDIAN
-1062.83%
vs the sector median at left
Cocrystal Pharma, Inc.
Market Cap
$15.30M
Interest Coverage Ratio
-65.53x
TTM Avg
-3616.63x
3Y Avg
-2533.14x
5Y Avg
-1763.13x
Market Cap
$15.25M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$15.07M
Interest Coverage Ratio
-1.98x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$15.81M
Interest Coverage Ratio
-68.14x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$14.44M
Interest Coverage Ratio
-38.62x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$14.51M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$16.49M
Interest Coverage Ratio
-15.67x
TTM Avg
0.81x
3Y Avg
0.81x
5Y Avg
0.81x
Market Cap
$13.97M
Interest Coverage Ratio
-18.73x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | $15.30M | -65.53x | -3616.63x | -2533.14x | -1763.13x |
| Pasithea Therapeutics Corp. (KTTA)vs › | $15.25M | N/A | N/A | N/A | N/A |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $15.07M | -1.98x | N/A | N/A | N/A |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.81M | -68.14x | N/A | N/A | N/A |
| Pulsenmore Ltd. Ordinary Shares (PLSM)vs › | $14.44M | -38.62x | N/A | N/A | N/A |
| Obsidian Therapeutics Inc. (OBX)vs › | $14.51M | N/A | N/A | N/A | N/A |
| BioCardia, Inc. (BCDA)vs › | $16.08M | N/A | N/A | N/A | N/A |
| Dyadic International, Inc. (DYAI)vs › | $16.49M | -15.67x | 0.81x | 0.81x | 0.81x |
| Vyome Holdings, Inc. (HIND)vs › | $13.97M | -18.73x | N/A | N/A | N/A |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $13.90M | -143.87x | N/A | N/A | N/A |
Interest Coverage
-65.5x
Debt/Equity
1.28
Current Ratio
1.24
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2023-03-31 | -65.53x |
| 2022-12-31 | -4502.00x |
| 2022-09-30 | -5694.00x |
| 2022-03-31 | -4205.00x |
| 2021-09-30 | -3953.00x |
| 2021-06-30 | -1914.00x |
| 2021-03-31 | -2738.00x |
| 2020-12-31 | -733.00x |
| 2020-09-30 | -1354.50x |
| 2020-06-30 | -1725.00x |
| 2020-03-31 | -980.50x |
| 2019-12-31 | -15975.00x |
| 2019-09-30 | -361.60x |
| 2019-06-30 | -310.00x |
| 2019-03-31 | 479.50x |
| 2018-12-31 | -18767.67x |
| 2018-06-30 | -88.83x |
| 2018-03-31 | -64.59x |
| 2017-12-31 | -305.33x |
| 2017-09-30 | -1055.00x |
| 2016-12-31 | -6292.40x |
| 2013-12-31 | -0.70x |
| 2013-09-30 | -0.41x |
| 2013-03-31 | -2.15x |
| 2012-12-31 | -5.23x |
| 2012-09-30 | 0.75x |
| 2012-06-30 | 0.12x |
| 2012-03-31 | -0.17x |
| 2011-12-31 | -1.06x |
| 2011-09-30 | -7.82x |
| 2011-06-30 | -4.23x |
| 2011-03-31 | -0.02x |
| 2010-09-30 | -0.13x |
| 2010-06-30 | -0.22x |
